Source: Annual Congress 2008 - Structural remodelling in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Prakash Muyal, A. Plagens, M. Herrmann, C. Vogelmeier, H. Fehrenbach, C. Seifart (Marburg Hessen, Germany). Influence of recombinant human vascular endothelium growth factor- (rhVEGF-) 165 on surfactant proteins (SPs) mRNA levels in emphysematous rat lungs. Eur Respir J 2008; 32: Suppl. 52, 700

Member's Comments

No comment yet.

Related content which might interest you: Production of a novel isoform of vascular endothelial growth factor (VEGF) by the normal human lung Source: Eur Respir J 2006; 28: Suppl. 50, 822s Year: 2006 Increased binding activity of hypoxia inducible factor (HIF)-1α to vascular endothelial growth factor (VEGF) promoter region mediates enhanced vascular permeability in the lung of cystic fibrosis (CF) patients Source: Eur Respir J 2003; 22: Suppl. 45, 173s Year: 2003 Effect of dexamethasone on TNFα-induced expression of vascular endothelial growth factor (VEGF) in human airway smooth muscle cells - role of histone-acetylation Source: Eur Respir J 2004; 24: Suppl. 48, 695s Year: 2004 Vascular endothelial growth factor (VEGF) isoform expression in primary human cultured alveolar epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 84s Year: 2003 Vascular endothelial growth factor (VEGF) mRNA isoforms in an animal model of acute lung injury Source: Annual Congress 2003 - Animal models of lung injury: useful or not? Year: 2003 Effects of PEEP-like cyclic stretch on the IL-6 protein production in normal human pulmonary artery endothelial cells in vitro Source: Annual Congress 2012 - The many roads to lung injury Year: 2012 Effects of hypoxia on VEGF and VEGF-R expression by human alveolar epithelial (ATII) and human pulmonary microvascular endothelial (HMVEC-l) cells Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury Year: 2008 Role of corticosteroids in TNFα-induced expression of vascular endothelial growth factor (VEGF) in human airway smooth muscle cells Source: Annual Congress 2003 - Cell signalling and cytokines in asthma Year: 2003 Haemophilus influenzae (NTHi) up-regulates acute inflammation in human lung tissue and causes downregulation of transforming growth factor-beta (TGF-beta) – A possible role of NTHi in remodeling processes in human lung tissue Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 The influence of sera from interstitial lung diseases (ILD) patients on human mononuclear cells (MNC) production of vascular endothelial growth factor (VEGF) Source: Eur Respir J 2004; 24: Suppl. 48, 553s Year: 2004 The effect of vascular endothelial growth factor (VEGF) on primary human cultured type 2 alveolar epithelial (AE2) cell proliferation Source: Annual Congress 2004 - Cellular injury and repair in the lung Year: 2004 Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro Source: Eur Respir J 2002; 20: 1449-1456 Year: 2002 VEGF induces ECM synthesis and fibroblast activity in human lung fibroblasts Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017 Upregulated expression and release of VEGF from human airway smooth muscle cells in relation to fibroblast growth factors Source: Annual Congress 2008 - Airway cell biology and immunology Year: 2008 Increased vascular endothelial growth factor (VEGF) secretion from activated T cells in COPD Source: Annual Congress 2007 - Cell-based tissue modulation: the good and the ugly? Year: 2007 Expression of insulin-growth factor-I (IGF-I) in alveolar lymphocytes (AL) in interstitial lung diseases (ILD). Potential functions of AL-derived IGF Source: Annual Congress 2005 - Progresses in lung fibrosis Year: 2005 CCL5 (RANTES) inhibits TGF-β1-induced collagen production in human bronchial epithelial cells by action of Smad protein Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009 Hepatocyte growth factor (HGF) expression in bronchoveolar lower (BAL) does not confirm its anti-fibrotic activity in interstitial lung diseases (ILD) Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Regulation of human adult primary alveolar type II cell surfactant protein production by epithelial growth factors and pro-inflammatory cytokines Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009 Expression and synthesis of connective tissue growth factor by human γδT-lymphocytes. Effect of interleukin-15 and transforming growth factor-β1 Source: Eur Respir J 2002; 20: Suppl. 38, 213s Year: 2002